Company / Book Value per Share
Vivos Therapeutics, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.253
FY2025
5-year range
-$0.253 / $27.742
FY2021-FY2025
Trend
-212.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed -213% YoY in FY2025, a notable deviation from the 5-year average annual change of +520%.
Based on SEC 10-K filings.
-$0.253 in FY2025.
Declined from $27.742 to -$0.253 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, book value per share decreased 212.9% year-over-year.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.253 | -212.9% |
| FY2024 | $0.224 | -99.2% |
| FY2023 | $27.742 | +2399.7% |
| FY2022 | $1.11 | +19.5% |
| FY2021 | $0.929 | +492.8% |
| FY2020 | -$0.237 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026